Organovo Holdings Inc ONVO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10/15/21 EDT
6.46quote price arrow down-0.26 (-3.87%)
Volume
65,016
52 week range
6.05 - 23.92
Loading...
  • Open6.71
  • Day High6.72
  • Day Low6.46
  • Prev Close6.72
  • 52 Week High23.92
  • 52 Week High Date02/11/21
  • 52 Week Low6.05
  • 52 Week Low Date08/20/21

Key Stats

  • Market Cap56.27M
  • Shares Out8.71M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change-47.48

KEY STATS

  • Open6.71
  • Day High6.72
  • Day Low6.46
  • Prev Close6.72
  • 52 Week High23.92
  • 52 Week High Date02/11/21
  • 52 Week Low6.05
  • 52 Week Low Date08/20/21
  • Market Cap56.27M
  • Shares Out8.71M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change-47.48

RATIOS/PROFITABILITY

  • EPS (TTM)-2.36
  • P/E (TTM)-2.74
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-13.726M
  • ROE (TTM)-53.41%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)95.64%
  • Net Margin (TTM)-5,977.18%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/07/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Organovo Holdings Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Organovo Holdings, Inc. is an early stage biotechnology company. The Company is focused on building high fidelity, three-dimensional (3D) tissues that recapitulate key aspects of human disease. The Company is targeting the intestine and has ongoing 3D tissue developments in Ulcerative colitis (UC) and Crohn's disease (CD). The Company uses its platform technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture...
Keith Murphy
Chairman
Thomas Hess
President
Thomas Jurgensen J.D.
General Counsel
Address
440 Stevens Avenue, Suite 200
Solana Beach, CA
92075
United States

Top Peers

SYMBOLLASTCHG%CHG
SYN
Synthetic Biologics Inc
0.4347-0.002-0.458%
MNPR
Monopar Therapeutics Inc
4.88-0.19-3.75%
ONTX
Onconova Therapeutics Inc
3.67UNCHUNCH
IDRA
Idera Pharmaceuticals Inc
0.94-0.0244-2.5301%
WINT
Windtree Therapeutics Inc
2.28UNCHUNCH
NERV
Minerva Neurosciences Inc
1.35-0.06-4.26%